|
2013
|
Debra A. Patt, M.D.
Clara Chen, M.S., Rahul Dhanda, Ph.D., Wan-Yu Tseng, M.S., Michael Forsyth, R.Ph., M.B.A.
|
American Society of Clinical Oncology
|
Evaluating Use Characteristics for the Oncotype Dx 21-Gene Recurrence Score and Concordance With Chemotherapy Use in Early-Stage Breast Cancer Download full publication here.
|
|
2013
|
Vivian J.M. Cline-Burkhardt
Tyvin A Rich,Kathryn Winter,Howard Safran,John P. Hoffman,Beth Erickson,Pramila R. Anne,Robert J. Myerson,Kimberly Perez,Christopher Willett
|
OncoTargets and Therapy
|
Paclitaxel, gemcitabine, irradiation, and R115777 for pancreas cancer Download full publication here.
|
|
2013
|
Vivian Jean M. Cline-Burkhardt, M.D.
J. Randolph Hecht, Allen Lee Cohn, Shaker R. Dakhil, Mansoor N. Saleh, Bilal Piperdi, Ying Tian, William Y. Go
|
ASCO University
|
SPIRITT (study 20060141): A randomized phase II study of FOLFIRI with either panitumumab (pmab) or bevacizumab (bev) as second-line treatment (tx) in patients (pts) with wild-type (WT) KRAS metastatic colorectal cancer (mCRC). Read the full publication here.
|
|
2012
|
John F. Sandbach, M.D.
Anne-Renee Hartman, M.D., Rajesh R. Kaldate, M.S., Lisa M. Sailer, M.S.N., Lisa Painter, M.S.N., Charles E. Grier, Ph.D., Robbin R. Endsley, M.S., Marlena Griffin, B.S., Stephanie A. Hamilton, B.A., Cynthia A. Frye, M.S., Mark A. Silberman, M.D. and Richard J.Wenstrup, M.D.
|
Hartman
|
Prevalence of BRCA Mutations in an Unselected Population of Triple-Negative Breast Cancer Download the full publication here.
|
|
2012
|
John Sandbach, M.D.
Lucy Langer, M.D., M.S.H.S., Lisa Clark, F.N.P., A.O.C.N.P., Justin Gress, Debra Patt, M.D., Neelima Denduluri, M.D., Yunfei Wang, Ph.D., Jay Andersen, M.D., Magdolna Solti, M.D., Amanda Wheeler, M.D., Tammy Delamelena, M.D., John Smith II, M.D.
|
|
A Structured Genetic Risk Evaluation and Testing Program in the Community Oncology Practice Increases Identification of Individuals at Risk for BRCA Mutations. Download the full publication here.
|
|
2012
|
John Sandbach, M.D.
Hartman AR, Kaldate RR, Sailer LM, Painter L, Grier CE, Endsley RR, Griffin M, Hamilton SA, Frye CA, Silberman MA, Wenstrup RJ.
|
Myriad Genetic Laboratories, Inc., Salt Lake City, Utah 84020, USA
|
Prevalence of BRCA mutations in an unselected population of triple-negative breast cancer. Read the full publication here.
|
|
2012
|
Weinthal, Joel, M.D.
|
Clinical Roundtable Monograph
|
Disease State Awareness in Gaucher Disease: A Q&A Expert Roundtable Discussion
Download full publication here
|
|
2010
|
Barrera, David N. D.O.
Nicholas Di Bella, Raymond Taetle, Kathryn Kolibaba, Thomas Boyd, Robert Raju, David Barrera, Ernest W. Cochran, Jr, Philip Y. Dien, Roger Lyons, Peter J. Schlegel, Svetislava J. Vukelja, Julie Boston, Kristi A. Boehm, Yunfei Wang, and Lina Asmar
|
Journal of the American Society of Hematology
|
Results of a phase 2 study of bortezomib in patients with relapsed or refractory indolent lymphoma
|
|
2009
|
Vukelja, Sasha M.D.
|
|
Seeds: A Memoir
|
|
2008
|
Esler, William Vance, M.D.
Lim, S.H., Zhang, Y., Zhang, J., Periman, P.O., Burris, C., Townsend, M.
|
Leukemia and Lymphoma
|
B-cell depletion for 2 years after autologous stem cell transplant for NHL induces prolonged hypogammaglobulinemia beyond the rituximab maintenance period.
|
|
2008
|
Esler, William Vance, M.D.
Lim, S.H., Periman, P.O., Beggs, D., Zhang, Y., and Townsend, M.
|
British Journal of Haematology
|
R-CHOP followed by consolidative autologous stem cell transplant and low dose rituxan maintenance therapy for advanced mantle cell lymphoma.
|
|
2008
|
Hoverman, J. Russell M.D.
Radebaugh, K.A.
|
American Society Clinical Oncology
|
Imaging in Early Breast Cancer
|
|
2008
|
Hutson, Thomas E. D.O., PharmD, FACP
MD Galsky.
|
Expert Review of Anticancer Therapy
|
Current optimal chemotherapy for advanced urothelial cancer.
|
|
2008
|
Jones, Stephen E. M.D.
Luc Yves Dirix, Jorge Ignacio, Shona Nag, Poonamally Bapsy, Henry Gomez,
Digumarti Raghunadharao, Robert Paridaens, Silvia Falcon, Marina Carpentieri, Antonello Abbattista, Jean-Pierre Lobelle
|
Journal of Clinical Oncology
|
Treatment of Advanced Hormone-Sensitive Breast Cancer in Postmenopausal Women With Exemestane Alone or in Combination with Celecoxib
|
|
2008
|
Lim, S.H. M.D.
Zhang, Y., Burris, C. and Townsend, M.
|
Bone Marrow Transplant
|
Successful salvage with unrelated umbilical cord blood transplant for Hodgkin’s disease relapsed following autologous stem cell transplant.
|
|
2008
|
McCollum, David M.D.
Richards D, Wilfong L, Sborov M, Boehm KA, Zhan F, and Asmar L.
|
Annals of Oncology
|
Phase II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer and/or adenocarcinoma of the gastroesophageal junction.
|
|
2008
|
Weintahl, Joel M.D.
Kishnani PS, Grabowski GA, Mistry PK, Weinreb NJ
|
|
CME Monograph sponsored by Duke University School of Medicine: Skeletal and hematologic pathology of Type-1 Gaucher disease.
|
|
2007
|
Barker Jr., Jerry L., M.D.
O’Daniel JC, Rosenthal DI, Garden AS, Ahamad A, Ang KK, Asper JA, Blanco AI, de Crevoisier R, Holsinger FC, Patel CB, Schwartz DL, Wang H, Dong L.
|
American Journal of Clinical Oncology
|
The effect of dental artifacts, contrast media, and experience on interobserver contouring variations in head and neck anatomy.
|
|
2007
|
Blum, Joanne L. M.D., Ph. D.
Kauff ND, Domcheck SM, Freibel TM, Robson ME, Lee J, Garber JE, Isaacs C, Evans DG, Lynch HT, Eeles RA, Neuhasusen SL, Daly MB, Matloff E, Norton L, Offit K, Rebbeck TR.
|
Journal of Clinical Oncology
|
Recall injury from vinblastine: a case report.
|
|
2007
|
Blum, Joanne L. M.D., Ph.D.
Freibel TM, Domcheck SM, Neuhausen SL, Wagner T, Evans DG, Isaacs C, Garber JE, Daly MB, Eeles R, Matloff E, Tomlinson G, Lynch HT, Tung N, Weitzel J, Rubinstein WS, Ganz PA, Couch F, Rebbeck TR.
|
Clinical Breast Cancer
|
Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 Mutation Carriers.
|
|
2007
|
Blum, Joanne L. M.D., Ph.D.
Savin M, Edelman G, Pippen J, Robert N, Geister B, Kirby R, Clawson A, O’Shaughessy J.
|
Clinical Breast Cancer
|
Phase 2 study of weekly nab-Paclitaxel for the treatment of patients with metastatic breast cancer heavily pretreated with taxanes.
|
|
2007
|
Blum, Joanne L. M.D., Ph.D.
Dees EC, Vukelja SJ, Amare M, Gill DP, McMahon RT, Ilegbodu D, Amar L, and O’Shaughnessy JA.
|
Clinical Breast Cancer
|
Phase II trial of capecitabine and weekly paclitaxel in patients with metastatic breast cancer previously treated with every-3-week taxane therapy.
|
|
2007
|
Estil A. Vance III, M.D.
Drew J. Winson, Jo-Anne H. Young, Vinod Pullarkat, Genovefa A. Papanicolaou, Ravi Vij, George J. Alangaden, Roy F., Chemaly, Finn Petersen, Nelson Chao, Jared Klein, Kellie Sprague, Stephen A. Villano, and Michael Boeckh.
|
Blood
|
Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem-cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study.
|
|
2007
|
Estil A. Vance III, M.D.
Agura E, Berryman R, Cooper B, Fay J, Holmes H, Maisel C, Molina A, Pineiro L.
|
|
Phase II study of clofarabine and cytosine arabinoside in adult patients with relapsede AML and in elderly patients with untreated AML who are at high risk of anthracycline toxicity.
|
|
2007
|
Fay, Joseph Wayne, M.D.
Palucka A, Banchereau J, Vence L, Connolly J, Uneo H.
|
Journal of Clinical Oncology
|
Compresensive analysis of melanoma antigen specific T cell repertoire. EPIMAX (Epitope MAXimum)
|
|
2007
|
Fay, Joseph Wayne, M.D.
Banchereau, J., Palucka, K
|
Journal of Clinical Oncology
|
Long-term survival in patients with metastatic melanoma vaccinated with melanoma-antigen loaded dendritic cells.
|
|
2007
|
Goldman, Stan M.D.
Rakheja D, Wilson K, Lenarsky C, Weinthal J, Schultz R.
|
Pediatric and Developmental Pathology
|
Translocation associated primitive round cell sarcoma: report of a case and review of the literature.
|
|
2007
|
Hellerstedt, Beth M.D.
Bosserman LD, Smith JA, Geier L.
|
|
Hereditary Cancer Testing in Community Oncology Practices.
|
|
2007
|
Hoverman, J. Russell M.D.
et. al.
|
Journal of Clinical Oncology
|
Assessment of medication safety in the outpatient setting.
|
|
2007
|
Hutson, Thomas E. DO, PharmD, FACP
|
Current Oncology Report
|
A novel multitargeted tyrosine kinase inhibitor.
|
|
2007
|
Hutson, Thomas E. DO, PharmD, FACP
BJ Roth
|
Oncologist
|
Management of recurrent testicular germ cell tumors.
|
|
2007
|
Hutson, Thomas E. DO, PharmD, FACP
K Chi, T Powles, CJ Sweeney, N Hahn, MD Galsky, WR Berry and D Kadman.
|
Cancer
|
Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer.
|
|
2007
|
Hutson, Thomas E. DO, PharmD, FACP
T Powles, CJ Sweeney, MD Galsky, N Hahn, and CN Sternberg.
|
British Journal of Urology International
|
Novel agents for urothelial cancer: review
|
|
2007
|
Hutson, Thomas E. DO, PharmD, FACP
George, T Mekhail, L Wood, J Finke, P Elson, R Dreicer, and RM Bukowski.
|
Cancer Chemotherapy and Pharmacology
|
Phase I trial of PEG-Intron and rIL-2 in patients with metastatic renal cell carcinoma
|
|
2007
|
Hutson, Thomas E. DO, PharmD, FACP
E Segota, T Mekhail, T Olencki, R Dreicer, B Wacker, B Osterwalder, P Elson, M Zhou, and RM Bukowski
|
Urology Oncology
|
Phase II trial of capecitabine and rHU-interferon-alpha-2a in patients with metastatic renal cell carcinoma, limited efficacy and moderate toxicity.
|
|
2007
|
Hutson, Thomas E. DO, PharmD, FACP
RJ Motzer, P Tomczak, MD Michaelson, RM Bukowski, O Rixie, S Oudard, S Negrier, C Szczylik, ST Kim, I Chen, CM Baum and RA Figlin
|
New England Journal of Medicine
|
Phase III randomized trial of sunitinib malate versus interferon-alfa as first-line systemic therapy for patients with metastatic renal cell carcinoma.
|
|
2007
|
Hutson, Thomas E. DO, PharmD, FACP
|
Expert Opinion on Biological Therapy
|
Recent advances in the therapy of renal cancer.
|
|
2007
|
Hutson, Thomas E. DO, PharmD, FACP
RA Figlin
|
The Cancer Journal
|
Renal Cell Carcinoma: Recent Advances.
|
|
2007
|
Hutson, Thomas E. DO, PharmD, FACP
|
Expert Review of Anticavity Therapy
|
Safety and tolerability of sorafenib in clear-cell renal cell carcinoma – a phase III overview.
|
|
2007
|
Hutson, Thomas E. DO, PharmD, FACP
|
Baylor Health Care Center Proceedings
|
Targeted therapy for renal cell carcinoma: A new treatment paradigm
|
|
2007
|
Hutson, Thomas E. DO, PharmD, FACP
RA Figlin
|
Oncology
|
The evolving role of novel targeted agents in renal cell carcinoma.
|
|
2007
|
Hutson, Thomas E. DO, PharmD, FACP
B. Escudier, T. Eisen, W.M. Stadler, C. Szczylik, S. Oudard, M. Siebels, S. Negrier, C. Chevreau, E. Solska, A. Desai, F. Rolland, T. Demkow, M. Gore, S Freeman, B Schwartz, M. Shan, R. Simantov, R.M. Bukowski for the Sorafenib TARGETs Clinical Trial Group.
|
New England Journal of Medicine
|
Treatment Approaches in Renal cancer Global Evaluation Trial (TARGETs)
|
|
2007
|
Jones, Stephen E. M.D.
|
Values in Health
|
Cost-Effectiveness of Switching to Exemestane Following Two-to-Three Years of Therapy with Tamoxifen in Postmenopausal Women with Early-Stage Breast Cancer
|
|
2007
|
Jones, Stephen E. M.D.
Coombes RC, Kilburn LS, Snowdon CF, Paridaens R, Coleman RE, Jassem J, Van deVelde CJH, Delozier T, Alvarez I, Del Mastro L, Ortmann O, Diedrich K, Coates AS, Bajetta E, Holmberg SB, Dodwell Dl, Mickiewicz E, Andersen J, Lonning PE, Cocconi G, Forbes J, Castiglione M, Stuart N, Stewart A, Fallowfield LJ, Bertelli G, Hall E, Bogle RG, Carpentieri M, Colajori E, Subar M, Ireland E, Bliss JM
|
The Lancet
|
Survival and Saftety of Exemestane Versus Tamoxifen After 2-3 Years Tamoxifen Treatment (Intergroup Exemestane Study)
|
|
2007
|
Jones, Stephen E. M.D.
|
Community Oncology
|
The AC vs TC Trial: A Personal Perspective.
|
|
2007
|
Jones, Stephen E. M.D.
Paterson, A.
|
Oncology Consultations
|
Treatment of a Patient with Estrogen Receptor-Positive/Progesterone Receptor-Negative Early-Stage Breast Cancer with Borderline Osteopenia.
|
|
2007
|
Lim, S.H. M.D.
Li, Z., Li, W., Meklat, F., Wang, Z., Zhang, J., Zhang, Y.
|
International Journal of Cancer
|
A yeast two-hybrid system using Sp17 identified Ropporin as a novel Cancer-Testis antigen in hematologic malignancies.
|
|
2007
|
Lim, S.H. M.D.
Meklat, F., Li, Z., Wang, Z., Zhang, Y., Zhang, J., Jewell, A.
|
British Journal of Haematology
|
Cancer-Testis antigens in haematologic malignancies.
|
|
2007
|
Lim, S.H. M.D.
Rohrer, J.E., and Bock, A.F.
|
American Journal of Hospice and Palliative Medicine
|
Medical condition is related to treatment preference in cancer patients: Implications for quality assessment.
|
|
2007
|
Mearley, J. Michael M.D.
Liming, J., McGuire, F.R., Ochran, T., Kerly, J.M., and McLemore, T.L.
|
Journal of Bronchology
|
Implantation of Radiotherapy Monitoring Devices Into Peripheral Lung Cancers via Electromagnetically Guided Bronchoscopy of Highly Selective External Beam Radiation Therapy
|
|
2007
|
Mearley, J. Michael M.D.
McLemore, T.L., Parkhill, B., and Ochran, T.G.
|
New England Journal of Medicine
|
Recurrent Pulmonary Neurofibromatosis Type 1 Successfully Treated with Endobronchial High Dose 192 Iridium Theraphy.
|
|
2007
|
Mennel, Robert G. M.D., FACP
Harris L, Fritsche H, Norton L, Ravdin P, Taube S, Somerfield MR, Hayes DF. Bast RC Jr.
|
Journal of Clinical Oncology
|
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.
|
|
2007
|
Munoz, Louis L. M.D.
Bowers, D., Gargan, L., Weprin, B., Mulne, Al, Elterman, R., Giller, C., and Winick, N.
|
1 Suppl. Pediatrics
|
Impact of Site of Tumor Reccurence Upon Survival of Children With Recurrent or Progressive Medulloblastoma .
|
|
2007
|
Patt, Debra M.D.
Duan, Zhigang. Fang, Shenying. Hortobagyi, Gabriel N. and Giordano, Sharon H.
|
Journal of Clinical Oncology
|
Acute Myeloid Leukemia after Adjuvant Breast Cancer Therapy in Older Women: Understanding Risk.
|
|
2007
|
Pippen, John E., JR. MD, F.A.C.P.
Jones SE, Cantrell J, Vukelja S, et al.
|
Journal of Clinical Oncology
|
Comparison of menopausal symptoms during the first year of adjuvant therapy with either exemestane or tamoxifen in early breast cancer: a report of a tamoxifen exemestane adjuvant multicenter trial substudy.
|
|
2007
|
Pippen, John E., JR. MD, F.A.C.P.
Gong Y, Yan K, et al.
|
The Lancet
|
Determination of oestrogen-receptor status and erb b2 status of breast carcinoma: a gene expression profiling study.
|
|
2007
|
Pippen, John E., JR. MD, F.A.C.P.
|
Journal of Oncology Practice
|
Maintenance of certification: my perspective.
|
|
2007
|
Pippen, John E., JR. MD, F.A.C.P.
Blum J, Savin M, Edelamn G, et al.
|
Clinical Breast Cancer
|
Phase II study of weekly albumin bound paclitaxel for patients with breast cancer heavily pretreated with taxanes.
|
|
2007
|
Shivnani, Anand M.D.
|
Journal of the American Medical Association
|
Adjuvant chemotherapy with gemcitabine for patients with resectable pancreatic cancer (Letter ot Editor)
|
|
2007
|
Shivnani, Anand M.D.
Small W Jr., Stryker SJ, et al.
|
American Journal of Surgery
|
Preoperative chemoradiation in rectal cancer: results of multimodality management and analysis of prognostic factors.
|
|
2007
|
Shivnani, Anand M.D.
|
New England Journal of Medicine
|
Prophylactic Cranial Irradiation in Extensive Small-Cell Lung Cancer.
|
|
2006
|
Balasubramanian, Lakshmi M.D.
Bennett CL, Evens AM, Andritsos LA, Mai M, Fisher MJ, Kuzel TM, Angelotta C, McKoy JM, Vose JM, Bierman PJ, Kuter DJ, Trifilio SM, Devine SM, Tallman MS.
|
British Journal of Haematology
|
Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project.
|
|
2006
|
Balasubramanian, Lakshmi M.D.
Evens, AM.
|
Current Opinions in Oncology
|
Targeting angiogenesis for the treatment of sarcoma.
|
|
2006
|
Barker Jr., Jerry L., M.D.
Rosenthal DI, Asper JA, Garden AS, Chao KSC, Morrison WH, Weber RS, Ang KK.
|
Head Neck
|
Importance of patient examination to clinical quality assurance in head and neck radiation.
|
|
2006
|
Berges, Daniel Farray, M.D.
Clark, J.I.
|
Clinical and Applied Immunology Reviews
|
Vaccine therapy of malignant melanoma.
|
|
2006
|
Blum, Joanne L. M.D., Ph.D.
O’Shaughnessy, JA.
|
Clinical Breast Cancer
|
Capecitabine/taxane combination therapy: evolving clinical utility in breast cancer.
|
|
2006
|
Blum, Joanne L. M.D., Ph.D.
Dees EC, Chacko A, Loane L, Ethirajan S, Hopkins J, McMahon R, Merten S, Negron A, Neubauer M, Ilegbodu D, Boehm K, Asmar L, O’Shaughnessy JA.
|
Journal of Clinical Oncology
|
Phase II trial of capecitabine and weekly paclitaxel as first-line therapy for metastatic breast cancer.
|
|
2006
|
Blum, Joanne L. M.D., Ph.D.
Jones SE, Savin MA. Holmes FA, O’Shaughnessy JA, Vukelja S, McIntryre KJ, Pippen JE, Kirby R, Sandbach J, Hyman WJ, Khandelwal P, Negron AG, Richards DA, Anthony SP, Mennel RG, Boehm KA, Mayer WG, and Asmar L,.
|
Journal of Clinical Oncology
|
Results of a Phase III trial doxoroubicin/cyclophosphamide (AC) compared to docetaxel/cyclophosphamide (TC) as adjuvant therapy for operable breast cancer.
|
|
2006
|
Cooper, Barry, M.D.
Gregory, T.F.
|
Baylor University Medical Center Proceedings
|
Case report of an acquired factor XIII inhibitor: diagnosis and management.
|
|
2006
|
Cooper, Barry, M.D.
Roberts, W.C.
|
Baylor University Medical Center Proceedings
|
MD: a conversation with the editor.
|
|
2006
|
Esler, William Vance, M.D.
Rohrer JE, Saeed Q, Saeed S, Periman P, Beggs D, Hancock P, Lim S.H.
|
Support Care Center
|
Risk of mistaken DNR orders.
|
|
2006
|
Fay, Joseph Wayne, M.D.
Ueno H, Connolly J, Banchereau J, Palucka AK
|
Journal of Clinical Oncology
|
Durable clinical responses in patients with metastatic melanoma vaccinated with dendritic cells loaded with killed allogeneic melanoma cells.
|
|
2006
|
Fay, Joseph Wayne, M.D.
Saracino, G, Agura, E., Berryman, B., Pineiro, L.
|
American Society of Hematology
|
Prevention of Graft-Versus-Host Disease (GVHD) with Tacrolimus after Allogeneic Grafting for Hematological Malignancies Following Sub-myeloablative Conditioning.
|
|
2006
|
Fay, Joseph Wayne, M.D.
Palucka AK, Nemunitis J, Weber J, Ueno H, Auditore-Hargreaves K, Banchereau J
|
Journal of Clinical Oncology
|
Vaccination of stage IV melanoma patients with dendritic cells generated ex vivo with type I interferon and loaded with heat-treated killed allogeneic melanoma cells – Preliminary report from the phase II clinical trial.
|
|
2006
|
Hellerstedt, Beth M.D.
Mackler NJ, Dunn RL, Cooney KA, Fardig J, Olson K, Pienta KJ, Smith DC.
|
Cancer
|
Dose Escalation of Oral Vinorelbine in Combination with Estramustine in Hormone-Refractory Adenocarcinoma of the Prostate
|
|
2006
|
Hoverman, J. Russell M.D.
Syrigos KN, Nutting CM, Roussos C, eds.
|
Tumors of the Chest - Biology, Diagnosis and Management
|
Financial Aspects of Lung Cancer.
|
|
2006
|
Hoverman, J. Russell M.D.
Hansen K, Richardson D, Shuey K.M., Dugger P.C.
|
Journal of Clinical Oncology
|
The Development of an Outpatient Chemotherapy Medication Safety Program.
|
|
2006
|
Hutson, Thomas E. DO, PharmD, FACP
RM Bukowski
|
Clinical Genitourinary Cancer
|
A phase II study of GW786034 using a randomized discontinuation design in patients with locally recurrent or metastatic clear-cell renal cell carcinoma.
|
|
2006
|
Hutson, Thomas E. DO, PharmD, FACP
TK Choueiri, T Mekhail, R Ganapathi, GE Kelly and RM Bukowski
|
Annals of Oncology
|
Phase I trial of phenoxodiol delivered by continuous intravenous infusion.
|
|
2006
|
Hutson, Thomas E. DO, PharmD, FACP
Galsky, and WR Berry
|
Journal of Clinical Oncology
|
Problems with randomized discontinuation design.
|
|
2006
|
Hutson, Thomas E. DO, PharmD, FACP
W Berry
|
Clinical Genitourinary Cancer
|
Systemic Chemotherapy for Urothelial Cancer.
|
|
2006
|
Hutson, Thomas E. DO, PharmD, FACP
RJ Halbert, RA Figlin, MB Atkins, M Bernal, TE Hutson, RG Uzzo, RM Bukowki, KD Khan, RJ Motzer, CG Wood, and R Dubois
|
Cancer
|
Treatment of Patients with Metastatic Renal Cell Carcinoma: A RAND appropriateness panel
|
|
2006
|
Jones, Stephen E. M.D.
Loesch D, Robert N, Elkordy M, Ilegbodu D, Asmar L
|
Journal of Oncology Practice
|
A Phase II Trial of a Novel Paclitaxel Schedule as Single-Agent, First-Line Therapy for HER2 neu-Negative Metastatic Breast Cancer
|
|
2006
|
Jones, Stephen E. M.D.
|
European Journal of Cancer Supplements
|
Head-to-Head: Docetaxel Challenges Paclitaxel
|
|
2006
|
Jones, Stephen E. M.D.
Savin MA, Holmes FA, O’Shaughnessy JA, Blum JL, Vukelja S, McIntyre K, Pippen JE, Kirby R, Sandbach J, Hyman WJ,
Khandelwal P, Negron AG, Richards DA, Anthony SP, Mennel RG, Boehm
KA, Meyer WG and Asmar L
|
Journal of Clinical Oncology
|
Phase III Trial Comparing Doxorubicin Plus Cyclophosphamide with Docetaxel Plus Cyclophosphamide as Adjuvant Therapy for Operable Breast Cancer
|
|
2006
|
Jones, Stephen E. M.D.
Fallowfield LJ, Bliss JM, Porter LS, Price M H, Snowdon CF, Coombes RC, Hall E
|
Journal of Clinical Oncology
|
Qualiity of Life in the Intergroup Exemestane Study: A Randomized Trial of Exemestane versus Continued Tamoxifen after 2 to 3 Years of Tamoxifen in Postmenopausal Women With Primary Breast cancer
|
|
2006
|
Jones, Stephen E. M.D.
|
Cancer Abstracts and Summaries
|
The Impact of Aromatase Inhibitors/Inactivators on Quality of Life, Serum Lipid Levels, and Bone Health
|
|
2006
|
Lim, S.H. M.D.
Wang, Z., Zhang, J., Zhang, Y., and Srivenugopal, K.S.
|
International Journal of Cancer
|
SPAN-XB core promoter sequence is regulated in myeloma cells by specific CpG dinucleotides associated with the MeCP2 protein.
|
|
2006
|
Lim, S.H. M.D.
Wang, Z., Zhang, J., Zhang, Y.
|
International Journal of Cancer
|
SPAN-Xb expression in myeloma cells is dependent on promoter hypomethylation and can be upregulated pharmacologically.
|
|
2006
|
McCollum, David M.D.
|
Proc (Bayl Univ Med Cent)
|
Stage III colon cancer at Baylor University Medical Center at Dallas and the Baylor Sammons Cancer Center: experience from 2000 to 2004.
|
|
2006
|
McCollum, David M.D.
Bingyan Wu, Jeffrey W. Clark, Matthew H. Kulke, Peter C. Enzinger, David P. Ryan, Craig Earle, Ann Michelini, Charles S. Fuchs, MD, MPH.
|
Americal Journal of Clinical Oncology
|
The Combination of Capecitabine and Thalidomide in Previously Treated, Refractory Metastatic Colorectal Cancer.
|
|
2006
|
Patt, Debra M.D.
Giordano, Sharon H.
|
Women's Health
|
Paclitaxel in Breast Cancer.
|
|
2006
|
Pippen, John E., JR. MD, F.A.C.P.
Dodwell, D.
|
Clinical Breast Cancer
|
Time to response: comparison of fulvestrant and oral endocrine agents.
|
|
2006
|
Shivnani, Anand M.D.
Rimel BJ, Schink J, and Small W Jr..
|
Oncology
|
Cancer of the Cervix: Current Management and New Approaches.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|